Cingulate

Cingulate Earnings Yield

The Earnings Yield of Cingulate (CING) as of Oct 21, 2026 is -27.33 %. In the previous year, Earnings Yield was -20.16 % — a change of 35.57% (lower).

Earnings Yield

-27.33 %

YoY

35.57%

Last updated:

Earnings Yield of Cingulate is 2025 -27.33 % . Earnings Yield of Cingulate was 2024 -20.16 % . It decreases by 35.57% lower compared to the previous year.

The Cingulate Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2019
-14.06 USD
Jan 1, 2020
-8.74 USD
Jan 1, 2021
-25.21 USD
Jan 1, 2022
-21.73 USD
Jan 1, 2023
-28.65 USD
Jan 1, 2024
-20.16 USD
Jan 1, 2025
-27.33 USD
The Cingulate Earnings Yield history
YEAREarnings YieldYoY
-27.33 %+35.57%
-20.16 %-29.64%
-28.65 %+31.85%
-21.73 %-13.81%
-25.21 %+188.29%
-8.74 %-37.78%
-14.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cingulate Stock analysis

What does Cingulate do? Cingulate Inc is a US-based biopharmaceutical company headquartered in Kansas City, Kansas, that focuses on the development, manufacturing, and commercialization of pharmaceutical products. The firm utilizes its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles designed to improve the lives of patients suffering from commonly diagnosed conditions. The company specifically targets the treatment of attention deficit/hyperactivity disorder (ADHD) through its innovative approach to drug delivery. The firm is currently developing two lead product candidates, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). These drug candidates both contain three releases of an active pharmaceutical ingredient combined into one small tablet dosage form. By employing this technology, Cingulate Inc aims to provide effective treatment options for ADHD across three core patient segments: children aged 6-12, adolescents aged 13-17, and adults aged 18 and older. Cingulate is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cingulate stock

Earnings Yield of Cingulate is -27.33 % in 2025.

Earnings Yield of Cingulate changed from -20.16 % to -27.33 %, representing a 35.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield Cingulate since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's Cingulate with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cingulate

All Key Metrics — Cingulate